6MK.DE Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 17:35):

Stats
Tagesvolumen	152.00
Durchschnittsvolumen	958.00
Marktkapitalisierung	308.48B
EPS	€0 ( 2024-04-24 )
Nächstes Ertragsdatum	( €0 ) 2024-05-28
Last Dividend	€0.730 ( 2023-09-14 )
Next Dividend	€0 ( N/A )
P/E	145.00
ATR14	€0 (0.00%)

Merck & Co Inc Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Merck & Co Inc Finanzdaten

Annual	2023
Umsatz:	€60.12B
Bruttogewinn:	€43.99B (73.17 %)
EPS:	€0.140

FY	2023
Umsatz:	€60.12B
Bruttogewinn:	€43.99B (73.17 %)
EPS:	€0.140

FY	2022
Umsatz:	€59.28B
Bruttogewinn:	€41.87B (70.63 %)
EPS:	€5.72

FY	2021
Umsatz:	€48.70B
Bruttogewinn:	€35.08B (72.02 %)
EPS:	€5.14

Financial Reports:

No articles found.

Merck & Co Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0.690 (N/A)	€0.730 (N/A)	€0.730 (N/A)	€0.730 (N/A)	€0.730 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

Merck & Co Inc Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.55 - Stable (30.93%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.380	2009-12-11
Last Dividend	€0.730	2023-09-14
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	56	--
Total Paid Out	€28.56	--
Avg. Dividend % Per Year	0.00%	--
Score	4.6	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.55
Div. Directional Score	8.48	--

Next Divdend (Est)
(2024-07-01)

€0.745 Estimate 22.11 %

Dividend Stability

0.59 Average

Dividend Score

4.60

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
ZOE.DE	Ex Dividend Knight	2023-07-20	Quarterly	0.00%
GIL.DE	Ex Dividend Junior	2023-05-15	Annually	0.00%
PRU.DE	Ex Dividend Knight	2023-09-07	Annually	0.00%
BEZ.DE	Ex Dividend Junior	2023-05-11	Annually	0.00%
IBM.DE	Ex Dividend Knight	2023-08-09	Quarterly	0.00%
SNW.DE	Ex Dividend Junior	2023-05-30	Annually	0.00%
CPIA.F	No Dividend Player	2023-06-29	Annually	0.00%
LHOG.F	Ex Dividend Junior	2023-08-24	Semi-Annually	0.00%
185.DE	Ex Dividend Junior	2023-08-07	Quarterly	0.00%
UTDI.DE	Ex Dividend Junior	2023-05-18	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.00607	1.500	9.88	10.00	[0 - 0.5]
returnOnAssetsTTM	0.00342	1.200	9.89	10.00	[0 - 0.3]
returnOnEquityTTM	0.00888	1.500	-1.012	-1.519	[0.1 - 1]
payoutRatioTTM	20.40	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	1.252	0.800	8.74	6.99	[1 - 3]
quickRatioTTM	0.679	0.800	-0.713	-0.570	[0.8 - 2.5]
cashRatioTTM	0.266	1.500	9.63	10.00	[0.2 - 2]
debtRatioTTM	0.329	-1.500	4.52	-6.78	[0 - 0.6]
interestCoverageTTM	3.18	1.000	9.93	9.93	[3 - 30]
operatingCashFlowPerShareTTM	5.13	2.00	8.29	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.61	2.00	8.20	10.00	[0 - 20]
debtEquityRatioTTM	0.933	-1.500	6.27	-9.40	[0 - 2.5]
grossProfitMarginTTM	0.732	1.000	1.138	1.138	[0.2 - 0.8]
operatingProfitMarginTTM	0.0598	1.000	-0.804	-0.804	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.371	1.000	9.05	9.05	[0.2 - 2]
assetTurnoverTTM	0.564	0.800	9.58	7.66	[0.5 - 2]
Total Score				10.41

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	900.94	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.00888	2.50	-0.651	-1.519	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.61	2.00	8.80	10.00	[0 - 30]
dividendYielPercentageTTM	2.31	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	5.13	2.00	8.29	10.00	[0 - 30]
payoutRatioTTM	20.40	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	45.64	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.216	1.000	7.09	0	[0.1 - 0.5]
Total Score				6.55

Merck & Co Inc

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.